NM_000202.8(IDS):c.1478G>A (p.Arg493His)
criteria provided, conflicting classifications. Learn more about how ClinVar calculates review status.
Likely pathogenic (1); Uncertain significance (4)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000202.8(IDS):c.1478G>A (p.Arg493His)
Variation ID: 968479 Accession: VCV000968479.10
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: Xq28 X: 149482921 (GRCh38) [ NCBI UCSC ] X: 148564452 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Jul 16, 2020 Feb 1, 2026 Oct 20, 2025 - HGVS
-
... more HGVS ... less HGVSNucleotide Protein Molecular
consequenceNM_000202.8:c.1478G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000193.1:p.Arg493His missense NM_000202.5:c.1478G>A NM_001166550.4:c.1208G>A NP_001160022.1:p.Arg403His missense NC_000023.11:g.149482921C>T NC_000023.10:g.148564452C>T NG_011900.3:g.27414G>A - Protein change
- R493H, R403H
- Other names
- -
- Canonical SPDI
- NC_000023.11:149482920:C:T
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD), exomes 0.00001
Exome Aggregation Consortium (ExAC) 0.00002
The Genome Aggregation Database (gnomAD), exomes 0.00002
- Links
Genes
| Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
|---|---|---|---|---|---|---|
| HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
| IDS | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
744 | 1766 | |
Conditions - Germline
| Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
|---|---|---|---|---|
| Conflicting classifications of pathogenicity (3) |
criteria provided, conflicting classifications
|
Aug 11, 2025 | RCV001243617.8 | |
| Uncertain significance (1) |
no assertion criteria provided
|
Apr 8, 2020 | RCV001829038.1 | |
| Uncertain significance (1) |
criteria provided, single submitter
|
Dec 29, 2018 | RCV002393637.2 | |
| Uncertain significance (1) |
criteria provided, single submitter
|
Oct 20, 2025 | RCV006453602.1 |
Submissions - Germline
| Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
Expand all rows
Collapse all rows
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
|---|---|---|---|---|---|
|
Likely pathogenic
(Nov 29, 2022)
C
Contributing to aggregate classification
|
criteria provided, single submitter
|
Mucopolysaccharidosis, MPS-II |
Laboratory of Medical Genetics, University of Torino
Study: NeuroWES
Accession: SCV002760127.1 First in ClinVar: Dec 11, 2022 Last updated: Dec 11, 2022 |
Observation: 1
Collection method: research
Allele origin: germline
Affected status: yes
Observation 1
Collection method: research
Allele origin: germline
Affected status: yes
|
|
|
Uncertain significance
(Dec 29, 2018)
C
Contributing to aggregate classification
|
criteria provided, single submitter
|
Inborn genetic diseases |
Ambry Genetics
Accession: SCV002699545.2
First in ClinVar: Nov 29, 2022 Last updated: May 01, 2024 |
Comment:
show
The p.R493H variant (also known as c.1478G>A), located in coding exon 9 of the IDS gene, results from a G to A substitution at nucleotide position 1478. The arginine at codon 493 is replaced by histidine, an amino acid with highly similar properties. Another alteration affecting the same amino acid, p.R493P (c.1478G>C), has been reported in a mucopolysaccharidosis cohort (Pollard LM et al. J. Inherit. Metab. Dis., 2013 Mar;36:179-87). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. (less)
Observation: 1
Collection method: clinical testing
Allele origin: germline
Affected status: unknown
Observation 1
Collection method: clinical testing
Allele origin: germline
Affected status: unknown
|
|
|
Uncertain significance
(Nov 27, 2024)
C
Contributing to aggregate classification
|
criteria provided, single submitter
|
Mucopolysaccharidosis, MPS-II |
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV001416785.3
First in ClinVar: Jul 16, 2020 Last updated: Feb 25, 2025 |
Comment:
show
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 493 of the IDS protein (p.Arg493His). This variant is present in population databases (rs782347729, gnomAD 0.02%), including at least one homozygous and/or hemizygous individual. This missense change has been observed in individual(s) with abnormal newborn screening results (PMID: 29801497, 36907694). ClinVar contains an entry for this variant (Variation ID: 968479). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt IDS protein function with a positive predictive value of 80%. This variant disrupts the p.Arg493 amino acid residue in IDS. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 22976778, 24515576, 31877959). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. (less)
Observation: 1
Collection method: clinical testing
Allele origin: germline
Affected status: unknown
Observation 1
Collection method: clinical testing
Allele origin: germline
Affected status: unknown
|
|
|
Uncertain significance
(Aug 11, 2025)
C
Contributing to aggregate classification
|
criteria provided, single submitter
|
Mucopolysaccharidosis, MPS-II |
Revvity Omics, Revvity
Accession: SCV006316195.1
First in ClinVar: Sep 06, 2025 Last updated: Sep 06, 2025 |
Observation: 1
Collection method: clinical testing
Allele origin: germline
Affected status: unknown
Observation 1
Collection method: clinical testing
Allele origin: germline
Affected status: unknown
|
|
|
Uncertain significance
(Oct 20, 2025)
C
Contributing to aggregate classification
|
criteria provided, single submitter
|
not specified |
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Accession: SCV007336491.1
First in ClinVar: Feb 01, 2026 Last updated: Feb 01, 2026 |
Comment:
show
Variant summary: IDS c.1478G>A (p.Arg493His) results in a non-conservative amino acid change in the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function all suggest that this variant is likely to be disruptive. The variant allele was found at a frequency of 1.6e-05 in 183355 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1478G>A has been observed in individuals affected with Mucopolysaccharidosis Type II (Hunter Syndrome) (Chuang_2018, Lin_2019, Burton_2023). These report(s) do not provide unequivocal conclusions about association of the variant with Mucopolysaccharidosis Type II (Hunter Syndrome). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 36907694, 29801497, 38053932, 35887520). ClinVar contains an entry for this variant (Variation ID: 968479). Based on the evidence outlined above, the variant was classified as uncertain significance. (less)
Observation: 1
Collection method: clinical testing
Allele origin: germline
Affected status: unknown
Observation 1
Collection method: clinical testing
Allele origin: germline
Affected status: unknown
|
|
|
Uncertain significance
(Apr 08, 2020)
N
Not contributing to aggregate classification
|
no assertion criteria provided
|
Mucopolysaccharidosis type IIIA |
Natera, Inc.
Accession: SCV002084455.1
First in ClinVar: Feb 13, 2022 Last updated: Feb 13, 2022 |
Observation: 1
Collection method: clinical testing
Allele origin: germline
Affected status: unknown
Observation 1
Collection method: clinical testing
Allele origin: germline
Affected status: unknown
|
|
Citations for germline classification of this variant
Help| Title | Author | Journal | Year | Link |
|---|---|---|---|---|
| Frequency of iduronate-2-sulfatase gene variants detected in newborn screening for mucopolysaccharidosis type II in Japan. | Hattori Y | Molecular genetics and metabolism reports | 2023 | PMID: 38053932 |
| Newborn screening for mucopolysaccharidosis type II: Lessons learned. | Burton BK | Molecular genetics and metabolism | 2023 | PMID: 36907694 |
| Newborn Screening Program for Mucopolysaccharidosis Type II and Long-Term Follow-Up of the Screen-Positive Subjects in Taiwan. | Lin HY | Journal of personalized medicine | 2022 | PMID: 35887520 |
| Identification and Functional Characterization of IDS Gene Mutations Underlying Taiwanese Hunter Syndrome (Mucopolysaccharidosis Type II). | Lin HY | International journal of molecular sciences | 2019 | PMID: 31877959 |
| Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan. | Chuang CK | Orphanet journal of rare diseases | 2018 | PMID: 29801497 |
| Enzyme Replacement Therapy in Mucopolysaccharidosis II Patients Under 1 Year of Age. | Lampe C | JIMD reports | 2014 | PMID: 24515576 |
| Molecular characterization of 355 mucopolysaccharidosis patients reveals 104 novel mutations. | Pollard LM | Journal of inherited metabolic disease | 2013 | PMID: 22976768 |
| Nigrostriatal pathway dysfunction in a methanol-induced delayed dystonia-parkinsonism. | Franquet E | Movement disorders : official journal of the Movement Disorder Society | 2012 | PMID: 22976778 |
Text-mined citations for rs782347729 ...
HelpRecord last updated Aug 16, 2026
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.
